These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 10494578

  • 1. Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors.
    Takahashi S, Sonehara K, Takagi K, Miwa T, Horikomi K, Mita N, Nagase H, Iizuka K, Sakai K.
    Psychopharmacology (Berl); 1999 Aug; 145(3):295-302. PubMed ID: 10494578
    [Abstract] [Full Text] [Related]

  • 2. Effects of sigma(1) receptor ligand MS-377 on D(2) antagonists-induced behaviors.
    Karasawa J, Takahashi S, Takagi K, Horikomi K.
    Pharmacol Biochem Behav; 2002 Oct; 73(3):505-10. PubMed ID: 12151023
    [Abstract] [Full Text] [Related]

  • 3. Effects of a novel, selective, sigma1-ligand, MS-377, on phencyclidine-induced behaviour.
    Takahashi S, Takagi K, Horikomi K.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jul; 364(1):81-6. PubMed ID: 11485043
    [Abstract] [Full Text] [Related]

  • 4. Effects of sigma(1) receptor ligand, MS-377 on apomorphine- or phencyclidine-induced disruption of prepulse inhibition of acoustic startle in rats.
    Yamada S, Yamauchi K, Hisatomi S, Annoh N, Tanaka M.
    Eur J Pharmacol; 2000 Aug 25; 402(3):251-4. PubMed ID: 10958892
    [Abstract] [Full Text] [Related]

  • 5. MS-377, a selective sigma receptor ligand, indirectly blocks the action of PCP in the N-methyl-D-aspartate receptor ion-channel complex in primary cultured rat neuronal cells.
    Karasawa J, Yamamoto H, Yamamoto T, Sagi N, Horikomi K, Sora I.
    Life Sci; 2002 Feb 22; 70(14):1631-42. PubMed ID: 11991251
    [Abstract] [Full Text] [Related]

  • 6. NE-100, a novel sigma receptor ligand: in vivo tests.
    Okuyama S, Imagawa Y, Ogawa S, Araki H, Ajima A, Tanaka M, Muramatsu M, Nakazato A, Yamaguchi K, Yoshida M.
    Life Sci; 1993 Feb 22; 53(18):PL285-90. PubMed ID: 7901723
    [Abstract] [Full Text] [Related]

  • 7. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
    Natesan S, Reckless GE, Barlow KB, Nobrega JN, Kapur S.
    Schizophr Res; 2008 Oct 22; 105(1-3):224-35. PubMed ID: 18710798
    [Abstract] [Full Text] [Related]

  • 8. DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'-oxoethyl)- piperidine HBr], a sigma and 5-hydroxytryptamine2 receptor antagonist: receptor-binding, electrophysiological and neuropharmacological profiles.
    Tam SW, Steinfels GF, Gilligan PJ, Schmidt WK, Cook L.
    J Pharmacol Exp Ther; 1992 Dec 22; 263(3):1167-74. PubMed ID: 1361572
    [Abstract] [Full Text] [Related]

  • 9. MS-377, a novel selective sigma(1) receptor ligand, reverses phencyclidine-induced release of dopamine and serotonin in rat brain.
    Takahashi S, Horikomi K, Kato T.
    Eur J Pharmacol; 2001 Sep 21; 427(3):211-9. PubMed ID: 11567651
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
    Zazpe A, Artaiz I, Innerárity A, Del Olmo E, Castro E, Labeaga L, Pazos A, Orjales A.
    Neuropharmacology; 2006 Jul 21; 51(1):129-40. PubMed ID: 16643965
    [Abstract] [Full Text] [Related]

  • 11. Binding properties of [3H]MS-377, a novel sigma receptor ligand, to rat brain membranes.
    Karasawa J, Takahashi S, Horikomi K.
    Eur J Pharmacol; 2000 Jul 14; 400(1):51-7. PubMed ID: 10913584
    [Abstract] [Full Text] [Related]

  • 12. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.
    Schotte A, Janssen PF, Megens AA, Leysen JE.
    Brain Res; 1993 Dec 24; 631(2):191-202. PubMed ID: 7510574
    [Abstract] [Full Text] [Related]

  • 13. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G, Depoortere R, Morel E, Sanger DJ, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan 24; 280(1):73-82. PubMed ID: 8996184
    [Abstract] [Full Text] [Related]

  • 14. Behavioural and electoencephalographic interactions between haloperidol and PCP/sigma ligands in the rat.
    Sagratella S, Scotti de Carolis A, Pèzzola A, Popoli P.
    Psychopharmacology (Berl); 1991 Jan 24; 105(4):485-91. PubMed ID: 1685250
    [Abstract] [Full Text] [Related]

  • 15. The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.
    Szewczak MR, Corbett R, Rush DK, Wilmot CA, Conway PG, Strupczewski JT, Cornfeldt M.
    J Pharmacol Exp Ther; 1995 Sep 24; 274(3):1404-13. PubMed ID: 7562515
    [Abstract] [Full Text] [Related]

  • 16. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S, Chaki S, Kawashima N, Suzuki Y, Ogawa S, Kumagai T, Nakazato A, Nagamine M, Yamaguchi K, Tomisawa K.
    Br J Pharmacol; 1997 Jun 24; 121(3):515-25. PubMed ID: 9179395
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.